Address |
50 Broadway London Greater London SW1 H0RG United Kingdom |
Employees | - |
Website | http://www.immupharma.com |
Updated | 07/08/2019 |
ImmuPharma Plc engages in the research, development, and commercialisation of pharmaceutical products. Its drug candidate, Lupuzor, is a potential treatment for the autoimmune chronic inflammatory disease lupus. The company was founded by Richard Warr and Dimitri F. |